What happens inside your horse’s joint after an injection, and why different joint treatments work in different ways.
Key takeaways
- A joint injection puts treatment straight into the joint, but what happens next depends entirely on what is injected.
- The synovial membrane, the thin lining of the joint, makes and manages the joint fluid and is a major site of inflammation in osteoarthritis.
- Arthramid works by integrating into that lining rather than sitting loose in the joint. In research on healthy horse joints, integration was evident by 14 days.
- Whether a treatment suits your horse is a decision for your veterinarian, based on the horse, the joint and the diagnosis.
“Joint injection” describes how a treatment is delivered, not what it does. Two horses can both have “had their joints done” with treatments that work in completely different ways. This guide covers the healthy joint, what changes when it becomes inflamed, how the main injections act, and where a newer approach fits.
What actually happens inside a horse’s joint?
A horse’s joint is a working biological system, not just two bone ends meeting. The bone ends are capped with smooth cartilage and enclosed in a joint capsule. That capsule is lined by the synovial membrane, which produces the synovial fluid that lubricates the joint and feeds the cartilage.
What is the synovial membrane? The synovial membrane, or synovium, is the thin inner lining of the joint capsule. It produces synovial fluid, the thick, slippery fluid that reduces friction, and controls the exchange of nutrients into the joint. This matters because cartilage has no blood supply of its own and relies on that fluid for nourishment.
A joint works best when the fluid is good quality, the lining is healthy and the joint is moved and loaded regularly. Keep the synovium in mind, because it is where different joint treatments start to part ways.
What changes when a horse’s joint becomes inflamed?
Osteoarthritis (OA) affects the whole joint, not only the cartilage. Inflammation of the joint lining, called synovitis, is a common feature of OA, and it changes the joint fluid in ways that affect comfort and function.
When the lining becomes inflamed, it thickens and the joint fills with extra fluid, the puffy joint you can see and feel. That fluid becomes thinner and less protective, and inflammatory signals from cells in the synovium break down cartilage and hold back its repair. Over time, that is how a sore joint becomes a worn one.
In work, this shows up as stiffness, heat, swelling or a shorter stride. Not every drop in performance is a joint problem, which is why diagnosis comes first. And because the lining and fluid are active parts of the problem, a treatment can target the joint environment itself, not only the pain.
What does a joint injection actually do?
An intra-articular injection puts a treatment directly inside the joint, so it acts where the problem is rather than travelling through the whole body. Intra-articular simply means “inside the joint”. What the treatment does once it is there depends on what was injected.
The route is the needle into the joint. The mechanism is what the treatment then does to the tissues around it. Your vet decides both after pinpointing the problem joint, usually with a lameness examination, nerve or joint blocks and imaging.
Do all horse joint injections work in the same way?
No. The joint injections commonly used in horses work through different pathways, some chemical, some biological and one mechanical, and they act mainly on different parts of the joint.
| Treatment | How it works | Main part of the joint it acts on | General role |
| Corticosteroids | Anti-inflammatory medicine that switches down inflammatory signalling | Synovial membrane and surrounding joint tissues | Reduce inflammation and pain |
| Hyaluronic acid | Supplements a natural component of joint fluid (viscosupplementation) | Synovial fluid | Support lubrication and fluid quality |
| Orthobiologics (PRP, IRAP) | Products prepared from the horse’s own blood to deliver signalling proteins | The joint’s biological environment | Influence the joint’s inflammatory and healing response |
| Arthramid (2.5% iPAAG) | Hydrogel that integrates into the synovial membrane | Synovial membrane and joint capsule | Supports the joint lining mechanically, with secondary downstream effects on inflammation and synovial signalling. |
Corticosteroids
Corticosteroids are anti-inflammatory medicines. Injected into the joint, they dampen the chemical signals that drive inflammation, which reduces swelling and pain. They have been used in equine joints for decades.
Hyaluronic acid
Hyaluronic acid (HA) is a normal part of healthy joint fluid and a big part of what makes it thick and slippery. Injecting it aims to restore the fluid’s lubricating quality, which is why it is often called viscosupplementation. HA products differ in molecular weight and formulation, so they are not interchangeable.
Orthobiologics
Orthobiologics are prepared from the horse’s own blood. Platelet-rich plasma (PRP) concentrates platelets and the growth factors they carry. Autologous conditioned serum (commonly known as ACS or IRAP) is serum processed to increase IL-1RA proteins that counter inflammation. Both aim to shift the joint’s biological response, and preparation varies between systems.
2.5% iPAAG
Arthramid is a 2.5% injectable polyacrylamide hydrogel, shortened to iPAAG. It is sometimes described as a gel that cushions the joint, but its defining feature is that it integrates into the synovial membrane and becomes part of the joint lining, rather than sitting loose in the joint space. 2.5% iPAAG is a soft, water-based hydrogel with a stable, cross-linked three-dimensional structure. It is biocompatible, which means the body does not break it down once it has been incorporated into the tissue.
What happens to Arthramid after it is injected?
After injection, 2.5% iPAAG progressively integrates into the synovial membrane. In a study of healthy horse joints, integration was evident by 14 days, with no free gel left in the joint cavity at that point.
Image: Joint after administration of Arthramid®. The synovial membrane produces the fluid responsible for joint lubrication, shock absorption, and cartilage support.
1. Injection. Your vet injects the gel into the joint.
2. Integration. The joint’s own clean-up cells, called macrophages, move into the gel along with small new blood vessels, and the gel becomes woven into the lining. This is a low-level, controlled tissue response: joint fluid stayed within clinically normal levels, with no scarring or mineral build-up.
3. Integrated. The gel remains in the lining as a three-dimensional scaffold with its structure intact. Research shows this makes the joint capsule less stiff and fibrotic. That is a mechanism, not a promised result for any particular horse.
That study used 10 healthy horses and 13 joints, not arthritic joints, so it shows what happens to the gel rather than how much it helps.
Newer research looks at joints with OA. A 2026 Colorado State University study induced OA in one knee of 16 horses, treating eight with 2.5% iPAAG and eight with saline. In the two weeks after treatment, synovial inflammatory signalling was switched down, while some immune pathways in the lining were switched up.
Because integration takes around two weeks, your vet will usually advise 48 hours of rest, then a reduced-impact workload for up to two weeks. If you would like to know whether this approach may suit your horse, talk to your veterinarian about Arthramid.
Why is that mechanism different?
The difference is where and how the treatment acts. Arthramid becomes part of the joint lining, while other common joint injections work on inflammation, the joint fluid or the joint’s biological signalling. That does not make one injection right for every horse.
Because the gel is bio-compatible, it stays in the tissue once integrated. For your vet, different mechanisms mean different tools, used alone or together depending on the case. One study in healthy horses found 2.5% iPAAG given alongside a corticosteroid in the same joint was well tolerated.
For a trainer, the practical point is that a treatment working on the joint lining is aimed at how the joint functions over time, not only how it feels this week. Whether that translates into soundness depends on the horse, the joint and the diagnosis.
What does this mean for trainers and owners?
Understanding how each joint injection works helps you have a better-informed conversation with your vet. It does not replace their assessment or their choice of treatment.
Mechanism is one factor. Your vet will also weigh the joint involved, how far the disease has progressed, the horse’s age, workload and upcoming campaign, and treatment history. Useful questions to ask: what is happening inside the joint, what will this treatment do there, what should the next few weeks of work look like, and how will we know it is working?
The goal is the one you have every day: a horse that stays comfortable and sound over the long term. To learn more about how Arthramid is used in horses, visit our Horse Owners and Trainers page, or read the clinical studies for the technical detail.
